Viewing Study NCT05438602


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-02-01 @ 9:08 PM
Study NCT ID: NCT05438602
Status: COMPLETED
Last Update Posted: 2024-09-23
First Post: 2022-06-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) View
None Coronavirus disease 2019 (COVID-19) View
None Paxlovid View
None Nirmatrelvir View
None Immunocompromised View